Conference Reports for NATAP

66th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 13-17 2015 Back

Short-Duration Therapy With Daclatasvir/Asunaprevir/Beclabuvir Fixed-Dose Combination Plus Sofosbuvir in Patients With Chronic Hepatitis C Genotype 1 (FOURward Study)       Reported by Jules Levin AASLD 2015 Nov 13-17 San Francisco   Sulkowski M,1 Flamm S,2 Kayali Z,3 Lawitz E,4 Kwo P,5 McPhee F,6 Torbeyns A,7 Hughes EA,8 Swenson ES,6 Yin PD,6 Linaberry M8 1Johns Hopkins University, Baltimore, MD; 2Northwestern University, Chicago, IL; 3Inland Empire Liver Foundation, Rialto, CA; 4The Texas Liver Institute, University of Texas Health Center, San Antonio, TX; 5Indiana University, Indianapolis, IN; 6Bristol-Myers Squibb, Wallingford, CT; 7Bristol-Myers Squibb, Braine l'Alleud, Belgium; 8Bristol-Myers Squibb, Princeton, NJ